TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
顏宗海Yen, Tzung-Hai
- 協同主持人
- 執行臨床試驗年資 22 年 9 個月
-
toxincg@gmail.com
-
yy5133@cgmh.org.tw
發表文獻
71筆
21
Chang PC, Tai SY, Hsu CL, Tsai AI, Fu JF, Wang IK, Weng CH, Yen TH*. Torus Mandibularis in Patients Receiving Hemodialysis. Int J Environ Res Public Health 2021; 18: 9451
22
Yen JS, Wang IK, Liang CC, Fu JF, Hou YC, Chang CC, Gu PW, Tsai KF, Weng CH, Huang WH, Hsu CW, Yen TH*. Cytokine changes in fatal cases of paraquat poisoning. Am J Transl Res 2021;13:11571-11584
23
Wang IK, Yu TM, Yen TH, Chiu LT, Lien LM, Sun Y, Wei CY, Hsu KC, Lai PC, Li CY, Sung FC*, Hsu CY. Taiwan stroke registry investigators. Renal dysfunction is associated with lower odds of home discharge for patients with stroke. Postgrad Med 2021;133:865-872
24
Chung YL, Hou YC, Wang IK, Lu KC, Yen TH*. Organophosphate pesticides and new-onset diabetes mellitus: from molecular mechanisms to a possible therapeutic perspective. World J Diabetes 2021;12:1818-1831
25
Hsiao HY, Nien CY, Hong HH, Cheng MH, Yen TH*. Application of dental stem cells in three-dimensional tissue regeneration. World J Stem Cells 2021;13: 1610-1624
26
Yeh H, Chiang CC, Yen TH*. Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges. World J Gastroenterol 2021; 27: 4104-4142
27
Yen JS, Wang IK, Yen TH*. COVID-19 Vaccination & Dialysis Patients: Why The Variable Response. QJM-INT J MED 2021;114:440-444
28
Fu JF*, Shih LY, Yen TH. HOXA11 plays critical roles in disease progression and response to cytarabine in AML. Oncol Rep. 2021;46:150
29
Yu JR, Hou YC, Fu JF, Wang IK, Chan MJ, Chen CY, Weng CH, Huang WH, Yang HY, Hsu CW, Yen TH*. Outcomes of elderly patients with organophosphate intoxication. Sci Rep 2021;11:11615
30
Wang IK, Yen TH, Hsieh PS, Ho HH, Kuo YW, Huang YY, Kuo YL, Li CY, Lin HC, Wang JY*. Effect of Probiotic Combinations in Experimental Mouse Model and Clinical Patients of Chronic Kidney Disease. Front Nutr 2021;8:661794
